Mercia Asset Management

LN: MERC

£94.6m market cap

21.5p last close

Mercia Asset Management is a regionally focused specialist asset manager. Its stated intent is to become the leading regional provider of supportive balance sheet, venture, private equity and debt capital in transaction sizes typically below £10m.

Investment summary

Life sciences is one of Mercia’s areas of focus and investment expertise. Seven of Mercia’s top 20 holdings at 31 March 2020 were in life sciences, valued at £29m in aggregate or 33% of total portfolio value (all of which had originated through Mercia’s third-party managed funds), with another c 40 earlier-stage life sciences investments across its third-party managed funds. COVID-19 has accelerated the opportunity for a new generation of novel and recombinant vaccines. This explosion of potential new treatments will require new diagnostics and bio-manufacturing support to scale supply once they are approved. These are areas where Mercia is already invested.

Y/E Mar
Revenue (£m)
EBITDA (£m)
PBT (£m)
EPS (p)
P/E (x)
P/CF (x)
2019A 10.7 (1.4) 3.0 1.00 21.5 N/A
2020A 12.7 0.2 (15.5) (4.55) N/A N/A
2021E N/A N/A N/A N/A N/A N/A
2022E N/A N/A N/A N/A N/A N/A
Industry outlook

Mercia’s management have set out a clear vision for the company, with the acquisition of NVM’s VCT business accelerating Mercia’s transition towards becoming a regionally focused specialist asset manager, managing fee-paying third-party funds and reducing its reliance on its own balance sheet. After a difficult 2019, investors have been seeing real value in the widened discounts to NAV in the sector as COVID-19 fears abate.

Last updated on 21/10/2020
Register to receive research on Mercia Asset Management as it is published

Richard Williamson

Analyst
Sector
TMT
Share price graph
Balance sheet
Forecast net debt (£m) N/A
Forecast gearing ratio (%) N/A
Price performance
%
1m
3m
12m
Actual 12.9 10.3 (17.9)
Relative* 12.1 17.3 (0.2)
52-week high/low 33.5p/13.8p
*% relative to local index
Key management
Dr Mark Payton CEO
Martin Glanfield CFO
Julian Viggars CIO
Company website

Content on Mercia Asset Management

Show all
mercia-globe-highres

Mercia Asset Management – Life sciences helping the COVID-19 fight

TMT research
Update
14 October 2020
mercia

Mercia Asset Management – executive interview

TMT Edison TV
12 October 2020
mercia-globe-highres

Mercia Asset Management – Scaling, sustainable and evergreen by FY22

TMT research
Update
20 July 2020
mercia-globe-highres

Mercia Asset Management – Successful exit of The Native Antigen Company

TMT research
Flash note
10 July 2020

You may also be interested in…

Cookies

This site uses cookies: Find out more.